Pharmacodynamics and Pharmacogenetics of OPB-51602 in Patients With Advanced Solid Tumours

Trial Profile

Pharmacodynamics and Pharmacogenetics of OPB-51602 in Patients With Advanced Solid Tumours

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2013

At a glance

  • Drugs OPB 51602 (Primary)
  • Indications Solid tumours
  • Focus Biomarker; Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 05 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top